Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19

Abstract The present Perspective examined the latest evidence on the association between the use of angiotensin‐converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and the incidence/mortality of coronavirus disease 2019 (COVID‐19). Our critical appraisal from existing litera...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Martin C.S. Wong, Sunny Wong, Junjie Huang, Bryan Yan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2020-10-01
Colecção:	ESC Heart Failure
Assuntos:	COVID‐19 Angiotensin‐converting enzyme inhibitor Angiotensin receptor blocker Severity Mortality
Acesso em linha:	https://doi.org/10.1002/ehf2.12952
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!